216 related articles for article (PubMed ID: 20174869)
1. Human stanniocalcin-1 or -2 expressed in mice reduces bone size and severely inhibits cranial intramembranous bone growth.
Johnston J; Ramos-Valdes Y; Stanton LA; Ladhani S; Beier F; Dimattia GE
Transgenic Res; 2010 Dec; 19(6):1017-39. PubMed ID: 20174869
[TBL] [Abstract][Full Text] [Related]
2. Human stanniocalcin-2 exhibits potent growth-suppressive properties in transgenic mice independently of growth hormone and IGFs.
Gagliardi AD; Kuo EY; Raulic S; Wagner GF; DiMattia GE
Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E92-105. PubMed ID: 15367391
[TBL] [Abstract][Full Text] [Related]
3. The murine stanniocalcin 2 gene is a negative regulator of postnatal growth.
Chang AC; Hook J; Lemckert FA; McDonald MM; Nguyen MA; Hardeman EC; Little DG; Gunning PW; Reddel RR
Endocrinology; 2008 May; 149(5):2403-10. PubMed ID: 18258678
[TBL] [Abstract][Full Text] [Related]
4. The proteolytic activity of pregnancy-associated plasma protein-A is potentially regulated by stanniocalcin-1 and -2 during human ovarian follicle development.
Jepsen MR; Kløverpris S; Bøtkjær JA; Wissing ML; Andersen CY; Oxvig C
Hum Reprod; 2016 Apr; 31(4):866-74. PubMed ID: 26874357
[TBL] [Abstract][Full Text] [Related]
5. Cell fate specification during calvarial bone and suture development.
Lana-Elola E; Rice R; Grigoriadis AE; Rice DP
Dev Biol; 2007 Nov; 311(2):335-46. PubMed ID: 17931618
[TBL] [Abstract][Full Text] [Related]
6. Stanniocalcin-1 and -2 promote angiogenic sprouting in HUVECs via VEGF/VEGFR2 and angiopoietin signaling pathways.
Law AY; Wong CK
Mol Cell Endocrinol; 2013 Jul; 374(1-2):73-81. PubMed ID: 23664860
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning of a second human stanniocalcin homologue (STC2).
Ishibashi K; Miyamoto K; Taketani Y; Morita K; Takeda E; Sasaki S; Imai M
Biochem Biophys Res Commun; 1998 Sep; 250(2):252-8. PubMed ID: 9753616
[TBL] [Abstract][Full Text] [Related]
8. Stanniocalcin 1 as a pleiotropic factor in mammals.
Yoshiko Y; Aubin JE
Peptides; 2004 Oct; 25(10):1663-9. PubMed ID: 15476933
[TBL] [Abstract][Full Text] [Related]
9. Mammalian stanniocalcins and cancer.
Chang AC; Jellinek DA; Reddel RR
Endocr Relat Cancer; 2003 Sep; 10(3):359-73. PubMed ID: 14503913
[TBL] [Abstract][Full Text] [Related]
10. Stanniocalcin-1 Potently Inhibits the Proteolytic Activity of the Metalloproteinase Pregnancy-associated Plasma Protein-A.
Kløverpris S; Mikkelsen JH; Pedersen JH; Jepsen MR; Laursen LS; Petersen SV; Oxvig C
J Biol Chem; 2015 Sep; 290(36):21915-24. PubMed ID: 26195635
[TBL] [Abstract][Full Text] [Related]
11. Prospect of a stanniocalcin endocrine/paracrine system in mammals.
Ishibashi K; Imai M
Am J Physiol Renal Physiol; 2002 Mar; 282(3):F367-75. PubMed ID: 11832417
[TBL] [Abstract][Full Text] [Related]
12. Identification of a stanniocalcin paralog, stanniocalcin-2, in fish and the paracrine actions of stanniocalcin-2 in the mammalian ovary.
Luo CW; Pisarska MD; Hsueh AJ
Endocrinology; 2005 Jan; 146(1):469-76. PubMed ID: 15486227
[TBL] [Abstract][Full Text] [Related]
13. Ameloblastin inhibits cranial suture closure by modulating MSX2 expression and proliferation.
Atsawasuwan P; Lu X; Ito Y; Zhang Y; Evans CA; Luan X
PLoS One; 2013; 8(4):e52800. PubMed ID: 23593111
[TBL] [Abstract][Full Text] [Related]
14. Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro.
Raulic S; Ramos-Valdes Y; DiMattia GE
J Endocrinol; 2008 Jun; 197(3):517-29. PubMed ID: 18492817
[TBL] [Abstract][Full Text] [Related]
15. Calvarial cleidocraniodysplasia-like defects with ENU-induced Nell-1 deficiency.
Zhang X; Ting K; Pathmanathan D; Ko T; Chen W; Chen F; Lee H; James AW; Siu RK; Shen J; Culiat CT; Soo C
J Craniofac Surg; 2012 Jan; 23(1):61-6. PubMed ID: 22337375
[TBL] [Abstract][Full Text] [Related]
16. EphA4 as an effector of Twist1 in the guidance of osteogenic precursor cells during calvarial bone growth and in craniosynostosis.
Ting MC; Wu NL; Roybal PG; Sun J; Liu L; Yen Y; Maxson RE
Development; 2009 Mar; 136(5):855-64. PubMed ID: 19201948
[TBL] [Abstract][Full Text] [Related]
17. Stanniocalcin 1 (STC1) protein and mRNA are developmentally regulated during embryonic mouse osteogenesis: the potential of stc1 as an autocrine/paracrine factor for osteoblast development and bone formation.
Yoshiko Y; Aubin JE; Maeda N
J Histochem Cytochem; 2002 Apr; 50(4):483-92. PubMed ID: 11897801
[TBL] [Abstract][Full Text] [Related]
18. Cranial sutures as intramembranous bone growth sites.
Opperman LA
Dev Dyn; 2000 Dec; 219(4):472-85. PubMed ID: 11084647
[TBL] [Abstract][Full Text] [Related]
19. Calvarial bone development and suture closure in Dicer-deficient mice.
Atsawasuwan P; Ouibaidin M; Dalal B; Khan H; Mohammed A
Orthod Craniofac Res; 2017 Jun; 20 Suppl 1(Suppl 1):26-31. PubMed ID: 28643928
[TBL] [Abstract][Full Text] [Related]
20. Stanniocalcin 1 acts as a paracrine regulator of growth plate chondrogenesis.
Wu S; Yoshiko Y; De Luca F
J Biol Chem; 2006 Feb; 281(8):5120-7. PubMed ID: 16377640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
